Key result
The 2025 ASE guidelines improve sensitivity for detecting elevated LAP to ~criteria.
Why the study?
Assessing diastolic dysfunction is clinically challenging, and the diagnostic performance of the recently published 2025 ASE guidelines for assessing left atrial pressure requires validation.
Does the 2025 ASE guideline improve the diagnostic performance for assessing left atrial pressure compared to the 2016 ASE/EACVI guideline in patients with normal LVEF?
Observational (n=119)
Does the 2025 ASE guideline improve the diagnostic performance for assessing left atrial pressure compared to the 2016 ASE/EACVI guideline in patients with normal LVEF?
Answers are grounded in this paper and cite their sources.
The 2025 ASE guidelines improve the sensitivity and feasibility of detecting elevated left atrial pressure in patients with normal LVEF compared to the 2016 guidelines, though with a reduction in specificity.
BACKGROUND: The assessment of diastolic dysfunction in patients is clinically challenging. The 2025 ASE guidelines for assessment of left atrial pressure were published recently and their diagnostic performance need further validation. OBJECTIVES: This study aimed to evaluate the diagnostic performance of the 2025 ASE guidelines for assessment of left atrial pressure and to compare it with that of the 2016 ASE/EACVI guidelines. METHODS: This study prospectively collected echocardiographic data and left atrial pressure (LAP) measurements from 119 patients. Patients were categorized into elevated left atrial pressure(ELAP) (LAP >15 mmHg) and normal (LAP ≤15 mmHg) groups. Both the 2016 ASE/EACVI and 2025 ASE guidelines were applied to assess diastolic function using echocardiographic parameters. RESULTS: The 2025 guidelines demonstrated significantly higher sensitivity (86.4% [75.7-93.6] vs. 54.0% [39.3-68.2]) and feasibility (100% [98.0-100] vs. 78.1% [72.2-84.0]) but lower specificity (81.8% [73.8-88.2] vs. 94.8% [88.3-98.3]) and positive predictive value (72.2% [63.7-79.3] vs. 84.4% [68.9-92.9]) compared to the 2016 guidelines. Negative predictive value (91.7% [85.6-95.3] vs. 79.8% [74.5-84.3]) and overall accuracy (83.4% [77.3-88.5] vs. 80.8% [73.5-86.9]) improved modestly. CONCLUSIONS: The 2025 guidelines significantly improved the feasibility of assessing LAP and enhanced ELAP detection rates and applicability while maintaining comparable accuracy.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) conducted an observational in Normal Left Ventricular Ejection Fraction (n=119). 2025 ASE guidelines vs. 2016 ASE/EACVI guidelines was evaluated on Sensitivity for detecting elevated left atrial pressure (>15 mmHg). The 2025 ASE guidelines demonstrated higher sensitivity and feasibility for detecting elevated left atrial pressure compared to the 2016 guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: